| Ytd | -36.92% | |
| 1y | -36.99% |
| Open | 11.44 | Prev Close | 11.51 | Low | 11.40 | High | 11.73 | Mkt Cap | 1.12B |
| Vol | 260.07K | Avg Vol | 594.61K | EPS | -0.29 | P/E | N/A | Forward P/E | 12.82 |
| Beta | N/A | Short Ratio | 5.56 | Inst. Own | 33.45% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 11.34 | 200-d Avg | 11.95 | 1yr Est | 17.57 |
Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and ra
RALEIGH, N.C., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging Holdings, Inc. (“Lumexa Imaging”) (N
The consensus price target hints at a 36.9% upside potential for Lumexa (LMRI). While empirical rese
Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call Transcript
Lumexa Imaging NASDAQ: LMRI reported second-quarter revenue growth, higher advanced-imaging volumes
Lumexa Imaging Holdings (NASDAQ:LMRI) affirms FY2026 Adj EPS guidance from $0.71-$0.77 to $0.71-$0.7
Lumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly earnings of $0.20 per share which beat the
RALEIGH, N.C., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's
RALEIGH, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's
Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation
The mean of analysts' price targets for Lumexa (LMRI) points to a 44.1% upside in the stock. While t
The consensus price target hints at a 73.3% upside potential for Lumexa (LMRI). While empirical rese
Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging servic
RALEIGH, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's
Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and lo
Lumexa Imaging Holdings, Inc. (LMRI) Q1 2026 Earnings Call Transcript
Lumexa Imaging NASDAQ: LMRI reported first-quarter results that management said were in line with ex
Lumexa Imaging Holdings (NASDAQ:LMRI) is looking for FY2026 Adj EPS of $0.71-$0.77 vs $0.73 analyst
Lumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly earnings of $0.18 per share which beat the
RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's l
RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's l
RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's
Proven healthcare growth leader to drive disciplined, profitable expansion and scale across Lumexa I
Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and lo
On April 8, 2026, Lumexa Imaging Holdings, Inc. (the "Company") held a meeting and site visi
Lumexa Imaging Holdings, Inc. (LMRI) Q4 2025 Earnings Call Transcript
Lumexa Imaging remains a Buy, with Q4 2025 results clarifying the medium-term growth and margin traj
SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims
Lumexa Imaging Holdings (NASDAQ:LMRI) sees FY2026 sales of $1.045 billion-$1.097 billion vs $1.066 b
Lumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly losses of $(0.20) per share which missed th
RALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's
Urgent.ly shares surged in pre-market trading after agreement to be acquired by Agero for $5.50 per
Raymond James analyst John Ransom upgrades Lumexa Imaging Holdings (NASDAQ:LMRI) from Outperform
Wall Street analysts initiate coverage on Lumexa Imaging, citing advanced imaging growth, expanding
Raymond James analyst John Ransom initiates coverage on Lumexa Imaging Holdings (NASDAQ:LMRI) wit
Barclays initiates coverage on Lumexa Imaging Holdings (NASDAQ:LMRI) with a Overweight rating and
Wells Fargo initiates coverage on Lumexa Imaging Holdings (NASDAQ:LMRI) with a Overweight rating a
William Blair analyst Ryan Daniels initiates coverage on Lumexa Imaging Holdings (NASDAQ:LMRI) wi
Deutsche Bank analyst Pito Chickering initiates coverage on Lumexa Imaging Holdings (NASDAQ:LMRI)
Leerink Partners initiates coverage on Lumexa Imaging Holdings (NASDAQ:LMRI) with a Outperform rat
Jefferies analyst Brian Tanquilut initiates coverage on Lumexa Imaging Holdings (NASDAQ:LMRI) wit
Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") announced today the pricing of its initial